Join Dr. Mark Garofoli on the front lines of the opioid crisis by earning a Pain Management Specialty Pharmacist (PMSP) Certificate
Combat the opioid crisis with freeCE's convenient & on-demand training programs!
freeCE provides pharmacies the opportunity to offer specialized training around the ‘best practices’ for pain management in the midst of the opioid crisis, making full use of ancillary and adjunctive options, both pharmacologic and non-pharmacologic.
Background
This program is pulls together principles from the prior units (Managing Opioids & Non-Opioid Pain Management), culminating in an extensive discussion of ‘best practices’ for pain management in the midst of the opioid crisis, making full use of ancillary and adjunctive options, both pharmacologic and non-pharmacologic.
Program Description
This 9-hour specialty certificate consists of 8 comprehensive modules specific to alternative options of pain management that lie outside of traditional opioid therapy options. This is part 3 of a three-part pain management program offered as a freeCE specialty certificate.
This session is part of the ancillary and adjunctive PMSP module, which highlights and summarizes best practices for incorporating ancillary and adjunctive therapies into an effective and appropriate pain management regimen. In this session, the role of healthcare is examined within the context of the broader opioid crisis, with a focus on how pharmacists may use MME calculations and other modalities to objectively calculate risk.
This session is part of the ancillary and adjunctive PMSP module, which highlights and summarizes best practices for incorporating ancillary and adjunctive therapies into an effective and appropriate pain management regimen. In this session, pain caused by physical damage to body tissue is examined from the perspectives of diagnosis, monitoring, and treatment.
This session is part of the ancillary and adjunctive PMSP module, which highlights and summarizes best practices for incorporating ancillary and adjunctive therapies into an effective and appropriate pain management regimen. In this session, specific ailments such as osteoarthritis, rheumatoid arthritis, and gout are carefully examined, underscoring the individualized strategies that are often required for effective management of pain originating from these sources.
This session is part of the ancillary and adjunctive PMSP module, which highlights and summarizes best practices for incorporating ancillary and adjunctive therapies into an effective and appropriate pain management regimen. In this session, specific ailments such as migraine headache, diabetic peripheral neuropathy, trigeminal neuralgia, post-herpetic neuralgia, post stroke pain, fibromyalgia, and complex regional pain syndrome (CPRS) are carefully examined, underscoring the individualized strategies that are often required for effective management of pain originating from these sources.
This session is part of the ancillary and adjunctive PMSP module, which highlights and summarizes best practices for incorporating ancillary and adjunctive therapies into an effective and appropriate pain management regimen. In this session, the pharmacist’s role in patient counseling is discussed, including the inclusion of naloxone education when appropriate. Moreover, real life scenarios are examined in which participants are challenged to select appropriate actions when misuse, abuse, or diversion is suspected.
This session is part of the ancillary and adjunctive PMSP module, which highlights and summarizes best practices for incorporating ancillary and adjunctive therapies into an effective and appropriate pain management regimen. In this session, the North American pain management guidelines and the 2016 CDC Chronic Pain Opioid Guidelines are examined and analyzed for central patient care components that can be immediately employed to develop an appropriate and complete pain management regimen.
This session is part of the ancillary and adjunctive PMSP module, which highlights and summarizes best practices for incorporating ancillary and adjunctive therapies into an effective and appropriate pain management regimen. In this session, the role of urine drug screening and urine drug tests are examined within the context of providing pain management services in the midst of the opioid crisis. Both benefits and limitations of these technologies are discussed, opening conversations about how one might best proceed with the data.
This session is part of the ancillary and adjunctive PMSP module, which highlights and summarizes best practices for incorporating ancillary and adjunctive therapies into an effective and appropriate pain management regimen. This session is dedicated to the appropriate management of patients who are at a higher risk of opioid abuse. Strategies for navigating the corresponding responsibility of the pharmacist are weighed with opportunities for intervention and patient referral resources. This session tackles the ‘difficult patient conversations’ and proposes proven strategies for effectively directing that communication.
Dr. Mark “Pain Guy” Garofoli is a 2004 graduate from the Pitt School of Pharmacy and a 2008 graduate of the Strayer University MBA program, and is a Board-Certified Geriatric Pharmacist (BCGP), Certified Pain Educator (CPE), and Certified Tobacco Treatment Specialist (CTTs), with APhA certificate training in Immunizations and Medication Therapy Management (MTM).
He began his career as a pharmacist and field management with CVS Health, then became an MTM pharmacist with Humana Healthcare, before initially joining the WVU School of Pharmacy by developing MTM and managed care pain management programs. Dr. Garofoli created and coordinated the West Virginia Expert Pain Management Panel, which developed the West Virginia Safe & Effective Management of Pain (SEMP) Guidelines. He is currently a Clinical Assistant Professor and Director of Experiential Learning for the WVU School of Pharmacy, along with being a Clinical Pain Management & Addiction Pharmacist at the WVU Medicine Center for Integrative Pain Management and faculty in the WVU School of Medicine Pain Fellowship.
Mark is also a 2021 TEDx Talk presenter and a recipient of the WV GenerationRx Award. Dr. Garofoli has consulted as CDC grant reviewer, an expert witness in multiple criminal and civil court cases, multiple advisory boards, and is the host of the Pain Pod on the Pharmacy Podcast Network while also developing and conducting presentations across the country revolving around pain management, substance-use disorder (addiction), substances of abuse, and drug diversion.
Some important notes to remember regarding the Pain Management Specialty Pharmacist: Ancillary and Adjunctive (PMSPAAPM) Certificate:
Registration costs $135 for members, $235 for non-members.
Once you have completed the specialty certificate, you are eligible to claim a sharable digital badge. Learn more about badges here.
This program's final exam consists of 50 unique multiple-choice questions.
You have only three (3) attempts to pass the final exam.
You may not leave the final exam in the middle and return at a later time.
The final exam has no time limit; however, we recommend that you write the answers down in case you lose your Internet connection or get interrupted while taking the exam.
You will earn continuing education credit as you complete each activity, totaling 9 credits upon final completion
You will have 12 months to complete the specialty certificate before it expires from your account.
This specialty certificate is accredited for pharmacists ONLY.
Indicates Completed Requirements
Requirements
Indicates Completed Requirements
Delivery Method
Prerequisite
Pain Management Specialty Pharmacist: Ancillary and Adjunctive Pain Management
